SR 38 New Jersey Senate · 2026-2027 Regular Session

Urges NJ DOH to increase public awareness on effects of xylazine.

SR 38 is a Senate Resolution urging the New Jersey Department of Health to increase public awareness about the dangers of xylazine, a non-opioid veterinary tranquilizer misused as a street drug. It directly affects New Jersey residents by calling for educational resources on xylazine's risks, including its link to overdose deaths (as it cannot be reversed by naloxone), skin ulcers, and dangerous combinations with fentanyl or other drugs. The resolution does not create new laws but requests the health department develop public outreach materials. It highlights xylazine's role in the Northeast overdose crisis, noting its use via injection, snorting, or mixing with opioids.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 1 co-sponsor

Sponsors